AIDS · 2005 · 53 citations · 15 references
MedicineNephrologyPharmacotherapyRenal PathologyRenal PathophysiologyRenal PharmacotherapyNephrotoxicity MechanismsRenal DiseaseRenal Function TestsRenal PharmacologyRenal ToxicityRenal Tubular DisordersKidney Function MonitoringRenal Phosphate ReabsorptionRenal Tubular DysfunctionRenal Tubular Function TestsRenal Tubular TransportSerum Creatinine AssessmentTubular Reabsorption KineticsTubular Toxicity
Despite its wide use, the renal tubular toxicity of tenofovir has not been fully evaluated. Twelve weeks after initiating a tenofovir-containing HAART regimen, a high urine-beta 2 microglobulin level was observed in 12 out of 17 patients, the percentage of tubular reabsorption of phosphate decreased from 96.0 to 91.1% and alkaline phosphatase increased from 294 to 365 U/l, whereas serum creatinine and phosphorus remained largely unchanged. Patients with the above findings should be monitored carefully for renal tubular toxicity.
15
Gabriel Birkuš, Michael J. M. Hitchcock, Tomáš Cihlář · Antimicrobial Agents and Chemotherapy · 2002 · 441 citations · Full text
Alexandre Karras, Matthieu Lafaurie, André Furco et al. · Clinical Infectious Diseases · 2003 · 363 citations · Full text